Genetic News and Research

RSS

New project aims to study growth of water-based microorganisms

In order to better understand and assess the quality of ground and spring water, state-of-the-art methods from the fields of molecular biology and microbiology, as well as chemical high-performance analytics are now developed.

14 Aug 2018

Scientists identify mutational signatures in ovarian cancer

Scientists have identified distinct patterns of genetic mutation among patients with ovarian cancer that could help them personalise treatment in the future.

14 Aug 2018

Research discoveries reveal insights behind neurological degeneration

Research discoveries revealing the genetic causes of neurological degeneration could be a key to slowing the progression of devastating diseases.

14 Aug 2018

Study compares genetic and neural contributions to ADHD in children with or without TBI

According to a study in Biological Psychiatry, physical brain injury in children contributes to the development of attention-deficit/hyperactivity disorder (ADHD), distinct from genetic risk for the disorder.

14 Aug 2018

New study focuses on promise of gene therapy for Amish nemaline myopathy

A new comprehensive natural history study about Amish nemaline myopathy in the Old Order Amish population focuses on the promise of gene therapy for this lethal disorder.

14 Aug 2018

New method provides a 'big picture' of genetic influences on traits and diseases

Scientists at Johns Hopkins Bloomberg School of Public Health have developed a powerful method for characterizing the broad patterns of genetic contributions to traits and diseases. The new method provides a "big picture" of genetic influences that should be particularly helpful in designing future genetic studies and understanding potential for genetic risk prediction.

14 Aug 2018

New genome analysis could identify people at higher risk of common deadly diseases

A research team at the Broad Institute of MIT and Harvard, Massachusetts General Hospital (MGH), and Harvard Medical School reports a new kind of genome analysis that could identify large fractions of the population who have a much higher risk of developing serious common diseases, including coronary artery disease, breast cancer, or type 2 diabetes.

13 Aug 2018

Altered nitrogen metabolism may contribute to emergence of new cancer mutations

Nitrogen is a basic building block of all the body's proteins, RNA and DNA, so cancerous tumors are greedy for this element. Researchers at the Weizmann Institute of Science, in collaboration with colleagues from the National Cancer Institute and elsewhere, have now shown that in many cancers, the patient's nitrogen metabolism is altered, producing detectable changes in the body fluids and contributing to the emergence of new mutations in cancerous tissue.

13 Aug 2018

New test predicts the risk of serious disease months before symptoms appear

Researchers have developed a new genetic test that can identify people who are at an increased risk of serious disease, long before they develop any symptoms.

13 Aug 2018

Researchers discover secret communication hotline between breast cancers and normal cells

Australian researchers have uncovered a secret communication hotline between breast cancers and the normal cells surrounding them. Importantly, the messages sent back and forth between the normal and tumour cells encourage the cancer to survive and to become more aggressive.

13 Aug 2018

Researchers develop revolutionary zebrafish model to gain more insight into bone diseases

Although much scientific research has been done into the development of the skeleton, the underlying mechanisms that drive the formation and maintenance of our bones are still not very well understood, and research into the development of our bone remains of enormous importance.

13 Aug 2018

Scientists pinpoint the cause of a rare childhood seizure disorder

Scientists have developed a set of computational tools that pinpoint the cause of Early Infantile Epileptic Encephalopathy (EIEE), a rare childhood disorder.

13 Aug 2018

Genetically modified mosquitoes and special bed nets help tackle deadly diseases

Researchers at the Imperial College’s South Kensington campus have successfully created genetically modified mosquitoes that would stop them from multiplying and spreading dreaded diseases such as malaria, Dengue, Chikungunya and Zika that kill millions worldwide annually.

13 Aug 2018

FDA approves first oral medication for treatment of adults with Fabry disease

The U.S. Food and Drug Administration today approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease.

10 Aug 2018

Genetic sequencing method identifies pathogens behind respiratory illnesses in Uganda

A study led by researchers at Center for Infection and Immunity at Columbia University's Mailman School of Public Health and the Department of Medicine at the Columbia University Irving Medical Center reports on the use of a genetic sequencing method to identify viral pathogens behind unexplained respiratory illnesses in Uganda over a five-year period.

10 Aug 2018

FDA approves first targeted RNA-based treatment for rare, fatal genetic disease

The U.S. Food and Drug Administration today approved Onpattro (patisiran) infusion for the treatment of peripheral nerve disease (polyneuropathy) caused by hereditary transthyretin-mediated amyloidosis (hATTR) in adult patients.

10 Aug 2018

Koala virus could provide clues to accumulated 'junk' DNA in the human genome

A koala virus could help researchers explain millions of years of accumulated ‘junk’ DNA in the human genome.

10 Aug 2018

Study yields new insights into why the system needs sleep

Sleep is essential for brain functionality and overall health but understanding how sleep delivers its beneficial effects remains largely unknown. In an article publishing on August 9 in the open access journal PLOS Biology, Shanaz Diessler and Maxime Jan at the University of Lausanne and the SIB Swiss Institute of Bioinformatics (Switzerland), sleep researchers are exploring new and unbiased approaches that can take sleep to a systems level.

10 Aug 2018

OGT announces launch of updated SureSeq Interpret NGS analysis software

Oxford Gene Technology, The Molecular Genetics Company, has announced the launch of the eagerly-anticipated update to its SureSeq Interpret software, included with purchases of SureSeq NGS panels.

From Oxford Gene Technology 10 Aug 2018

Using CRISPR-Cas9 genome editing to correct mutation responsible for sickle cell disease

Genome editing using the CRISPR-Cas9 system has tremendous promise for therapeutic correction of genetic errors in human cells. Prior to adoption as a medical therapeutic, safety concerns relating to off-target effects must be minimized to mitigate risks that may arise from the unintended action of this system at sites similar, but not identical, to the desired gene target site.

From Integrated DNA Technologies 10 Aug 2018

Genetic News and Research

New project aims to study growth of water-based microorganisms

Scientists identify mutational signatures in ovarian cancer

Research discoveries reveal insights behind neurological degeneration

Study compares genetic and neural contributions to ADHD in children with or without TBI

New study focuses on promise of gene therapy for Amish nemaline myopathy

New method provides a 'big picture' of genetic influences on traits and diseases

New genome analysis could identify people at higher risk of common deadly diseases

Altered nitrogen metabolism may contribute to emergence of new cancer mutations

New test predicts the risk of serious disease months before symptoms appear

Researchers discover secret communication hotline between breast cancers and normal cells

Researchers develop revolutionary zebrafish model to gain more insight into bone diseases

Scientists pinpoint the cause of a rare childhood seizure disorder

Genetically modified mosquitoes and special bed nets help tackle deadly diseases

FDA approves first oral medication for treatment of adults with Fabry disease

Genetic sequencing method identifies pathogens behind respiratory illnesses in Uganda

FDA approves first targeted RNA-based treatment for rare, fatal genetic disease

Koala virus could provide clues to accumulated 'junk' DNA in the human genome

Study yields new insights into why the system needs sleep

OGT announces launch of updated SureSeq Interpret NGS analysis software

Using CRISPR-Cas9 genome editing to correct mutation responsible for sickle cell disease

eBook: Using iPSCs models for human disease research and drug discovery eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News